Feasibility of acupuncture and moxibustion treatment for sequelae after COVID-19 infection: a prospective case series

Not Applicable

Completed

• Conditions: Certain infectious and parasitic diseases

• Registration Number: KCT0007394
• Lead Sponsor: Kyunghee University-industry Cooperation Foundation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-12-31
• Last Update Posted: 4 April 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

1. Those who have been diagnosed with COVID-19 and have been quarantined (and cured) for at least one month.
2. Adults between 20 and 65 years of age
3. Those who complain of at least one of the following symptoms that have persisted for more than 4 weeks after being cured of COVID-19, and whose symptom intensity of 4 or higher on the 0-10 numeric rating scale
3-1 Those who complain of fatigue
3-2 Those who complain of orfactory disturbance
3-3 Those who complain of alopecia
3-4 Those who complain of arthralgia
4. Those who voluntarily agree to participate in the study through a written consent form after being clearly explained of the purpose and characteristics of this case series study

Exclusion Criteria

1. Those with the following diseases
Those who have a history of diseases or surgical operation that can cause sequelae (fatigue, olfactory disturbance, alopecia, arthralgia etc) before the infection of COVID-19
Fatigue: Those who have been diagnosed as cancer, anemia, hypothyroidism or psychiatric disease such as depression
Orfactory disturbance: Those who have been diagnosed as rhinitis, polyp, head and neck cancer, or have had radiotherapy or chemotherapy, or have been exposed to chemicals which affect olfactory sense such as pesticides, and organic solvents
Alopecia: Those who have been diagnosed as scalp skin disease or have had follicular unit hair transplantation, radiotherapy or chemotherapy
Arthralgia: Those who have been diagnosed as rheumatoid arthritis, cancer, fracture or have had relative orthopedic surgery
1-2 Those who have a fear of acupuncture and moxibustion treatment
2. Women who are pregnant, may become pregnant or are lactating
3. Those who are judged that it is difficult to comply with this treatment protocol, visiting the hospital, or filling in a questionnaire, etc.
4. Those who are participating in another clinical study
5. Subjects who are judged to be inappropriate for the clinical study by the researchers

Study & Design

• Study Type: Observational Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
0-10 numeric rating scale (NRS)

Secondary Outcome Measures

Name	Time	Method
Study design and subject compliance to acupuncture and moxibustion treatment;Selection rate during the study period (%);Fatigue assessement scale (FAS);Fatigue severity scale (FSS);Brief fatigue inventory (BFI));Cross-cultural smell identification test (CC-SIT);Questionnaire of olfactory disorders (QOD);The severity alopecia tool (SALT);Visual evaluation (photo);Brief pain inventory-short form (BPI-SF);EuroQoL-5Dimension-5L (EQ-5D-5L);Measure yourself medical outcome profile (MYMOP2);Concomitant medications and changes in treatment history;Was it Worth It (WIWI) questionnaires;Adverse event evaluation after acupuncture and moxibustion treatment